NYSE · EW
Edwards Lifesciences Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for EW: Nov 04, 2026
Edwards Lifesciences Corporation Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 9 analysts' forecasts, the consensus EPS forecast for the quarter is $0.73. The reported EPS for the same quarter last year was $0.67.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.73 | $0.75 | $0.72 | 9 |
| Dec 2026 | $0.71 | $0.74 | $0.67 | 8 |
| Mar 2027 | $0.84 | $0.87 | $0.79 | 5 |
| Jun 2027 | $0.86 | $0.90 | $0.83 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · RTTNews- Zacks · 3 h agoCurious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key MetricsBeyond analysts' top-and-bottom-line estimates for Edwards Lifesciences (EW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.
- BNK Invest · Oct 29, 4:40 PM EDTEdwards Lifesciences Takes Over #217 Spot From AutodeskIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Edwards Lifesciences Corp (Symbol: EW) has taken over the #217 spot from Autodesk Inc (Symbol: ADSK), according to The Online Investor. Market capitalization is an im
- Zacks · Oct 28, 11:16 AM EDTSYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.
- Zacks · Oct 28, 11:16 AM EDTProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.
- Zacks · Oct 27, 8:39 AM EDTWST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.
- Zacks · Oct 27, 8:23 AM EDTGEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?GEHC heads into Q3 earnings with strong imaging demand and a record backlog, but PCS weakness, inflation and supply challenges could weigh on margins.
- Zacks · Oct 23, 10:37 AM EDTINSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.
- Zacks · Oct 22, 1:38 PM EDTDaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?DaVita's 55.6% stock rally reflects stronger operating execution, improving treatment volumes and value-based kidney care gains despite reimbursement pressures.
- Zacks · Oct 22, 1:21 PM EDTBDX Stock Gains 25.5% in Six Months: What's Behind the Rally?BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.
- Zacks · Oct 22, 7:48 AM EDTIs This the Right Time to Hold EW Stock in Your Portfolio?Edwards Lifesciences' TMTT and TAVR growth, strong clinical evidence and solid balance sheet support expansion, but tariffs and currency headwinds threaten margins.
- RTTNews · Oct 21, 9:51 AM EDTEdward Wins FDA Approval For PASCAL System In Tricuspid Valve Disease(RTTNews) – Edwards Lifesciences (EW) announced that the U.S. FDA has approved the PASCAL Precision System for tricuspid valve repair, providing a new treatment option for certain patients with severe tricuspid regurgitation.
- Zacks · Oct 21, 8:33 AM EDTIntuitive Surgical's Q3 Earnings Beat Estimates on Strong System SalesISRG's Q3 2026 earnings beat estimates as strong system placements, rising procedure volumes and improving margins fuel double-digit revenue growth.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Edwards Lifesciences Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.